Cellabs Competitors and Similar CompaniesClear all
Cellabs's competitors and similar companies include BioCryst Pharmaceuticals, Aptuit, Bioiberica and Fortress Biotech.
 Cellabs Cellabs is a biotechnology company specializing in the design, development, and manufacture of immunodiagnostic kits for tropical and infectious diseases. |  BioCryst Pharmaceuticals BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases. |  Aptuit Aptuit is a pharmaceutical services company that delivers early discovery to mid-phase drug development solutions. |  Bioiberica Bioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules. |  Fortress Biotech Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products. | |
Founding Date | Founding Date 1985 | Founding Date 1986 | Founding Date 1993 | Founding Date 1975 | Founding Date 2006 |
Type | Type Private | Type Public | Type Subsidiary | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Brookvale, AU HQ | Locations Durham, US HQ Hoover, US | Locations Greenwich, US HQ Verona, IT Reinach, CH Milton, GB | Locations Esplugues de Llobregat, ES HQ Barcelona, ES Palafolls, ES | Locations New York, US HQ Waltham, US |
Employees | Employees N/A | Employees 14040% increase | Employees 761 | Employees 332 | Employees 10146% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.7 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 55.7 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $874.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $346.7m (FY, 2018) | Revenue (est.) $63.3m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $19.1m (FY, 2025) | Cost of goods N/A | Cost of goods $190.3m (FY, 2018) | Cost of goods $20.9m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $855.8m (FY, 2025) | Gross profit N/A | Gross profit $156.4m (FY, 2018) | Gross profit $42.3m (FY, 2025) |
Net income | Net income N/A | Net income $263.9m (FY, 2025) | Net income N/A | Net income $40.5m (FY, 2018) | Net income ($32.9m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
BioCryst Pharmaceuticals
HQ
Durham, US
Employees
140↑ 40% increase
BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases.
View companyAptuit
HQ
Greenwich, US
Aptuit is a pharmaceutical services company that delivers early discovery to mid-phase drug development solutions.
View companyBioiberica
HQ
Esplugues de Llobregat, ES
Bioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules.
View companyFortress Biotech
HQ
New York, US
Employees
101↓ 46% decrease
Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products.
View company